Search research articles
Contact Us
Filters
Showing results (1-10 of 100) with videos related to
Page
of 10
Sort By:
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
May 5, 2000
Antimicrobial resistance in Brazil: comparison of results from two multicenter studies
H S Sader
Sao Paulo Medical Journal = Revista Paulista De Medicina
|
October 1, 1994
E test: a novel technique for antimicrobial susceptibility testing
H S Sader, A C Pignatari
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
August 1, 1994
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies
H S Sader, R N Jones
Drugs
|
May 23, 2001
Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents
H S Sader, A C Gales
American Journal of Surgery
|
October 1, 1992
Cefotaxime is extensively used for surgical prophylaxis
H S Sader, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 1, 1993
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs
H S Sader, R N Jones
Diagnostic Microbiology and Infectious Disease
|
August 1, 1995
Evaluation of Vitek and API 20S for species identification of enterococci
H S Sader, D Biedenbach, R N Jones
Journal of Clinical Microbiology
|
October 30, 2001
Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients
S Silbert, A L Barth, H S Sader
Journal of Chemotherapy (Florence, Italy)
|
November 26, 2009
Update on the in vitro activity of daptomycin tested against 17,193 Gram-positive bacteria isolated from European medical centers (2005-2007)
H S Sader, G Moet, R N Jones
Antimicrobial Agents and Chemotherapy
|
October 4, 2017
<i>In Vitro</i> Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program
R K Flamm, P R Rhomberg, H S Sader
Page
of 10
Search research articles
Search
Showing results (1-10 of 100) with videos related to
Sort By:
Page
of 10
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
May 5, 2000
Antimicrobial resistance in Brazil: comparison of results from two multicenter studies
H S Sader
Sao Paulo Medical Journal = Revista Paulista De Medicina
|
October 1, 1994
E test: a novel technique for antimicrobial susceptibility testing
H S Sader, A C Pignatari
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
August 1, 1994
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies
H S Sader, R N Jones
Drugs
|
May 23, 2001
Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents
H S Sader, A C Gales
American Journal of Surgery
|
October 1, 1992
Cefotaxime is extensively used for surgical prophylaxis
H S Sader, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 1, 1993
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs
H S Sader, R N Jones
Diagnostic Microbiology and Infectious Disease
|
August 1, 1995
Evaluation of Vitek and API 20S for species identification of enterococci
H S Sader, D Biedenbach, R N Jones
Journal of Clinical Microbiology
|
October 30, 2001
Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients
S Silbert, A L Barth, H S Sader
Journal of Chemotherapy (Florence, Italy)
|
November 26, 2009
Update on the in vitro activity of daptomycin tested against 17,193 Gram-positive bacteria isolated from European medical centers (2005-2007)
H S Sader, G Moet, R N Jones
Antimicrobial Agents and Chemotherapy
|
October 4, 2017
<i>In Vitro</i> Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program
R K Flamm, P R Rhomberg, H S Sader
Page
of 10